CAS 2403-88-5 - China Factory, Suppliers, Manufacturers

CAS 2403-88-5, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2,2,6,6-Tetramethyl-4-Piperidinol CAS 2403-88-5 Purity 99.0 (GC) (T) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2,2,6,6-Tetramethyl-4-Piperidinol CAS 2403-88-5 Purity >99.0% (GC) (T)
Read More

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

The Third Conference on Boron Chemistry of Chinese Chemical Society (CCS-CBS) will be held in Suzhou, Jiangsu Province from October 15 to 18, 2021. This conference will be hosted by Inorganic Chemi...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...

2022.12.20 19:11:09
2022.12.01 06:11:56
2022.03.16 20:00:37
2022.02.27 01:24:27
2021.12.09 23:15:10
2021.10.24 03:22:47

CAS 2403-88-5 - China Factory, Suppliers, Manufacturers

Related Products

2,2,6,6-Tetramethyl-4-Piperidinol CAS 2403-88-5 Purity >99.0% (GC) (T)

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

4-Chloroquinoline CAS 611-35-8 Purity >99.0% (GC) Factory

6-Bromoindazole CAS 79762-54-2 Purity >98.0% (HPLC) Factory

2,2-Difluoroethyl Acetate (DFEA) CAS 1550-44-3 Purity >98.0% (GC) Battery Additive

Cefotiam Hydrochloride CAS 66309-69-1 API USP Standard High Purity

2-Aminoindane Hydrochloride CAS 2338-18-3 Purity >99.0% (GC) Factory

5-Fluoro-2-Methoxybenzoic Acid CAS 394-04-7 High Quality

H-His(1-Me)-OH CAS 332-80-9 1-Methyl-L-Histidin Purity >98.0% (TLC)

4-Chloro-4'-Fluorobutyrophenone CAS 3874-54-2 Purity >98.0% (HPLC)

Methyl Isobutyrylacetate IBEM CAS 42558-54-3 Purity ≥98.0% (GC) Atorvastatin Calcium Intermediate Factory

Furan CAS 110-00-9 (Stabilized with BHT) Purity >99.0% (GC)

3-Chloroperoxybenzoic Acid mCPBA CAS 937-14-4 Purity 85.0%

Arginine Butyrate CAS 80407-72-3 Assay >98.0%

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

New COVID treatments offer hope

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The Third Conference on Boron Chemistry of Chinese Chemical Society，CCS-CBS-III

Paxlovid: what we know about Pfizer's Covid-19 pill

2022.12.20 19:11:09

2022.12.01 06:11:56

2022.03.16 20:00:37

2022.02.27 01:24:27

2021.12.09 23:15:10

2021.10.24 03:22:47

related search